While there is evidence of the anti-inflammatory behavior of NURR1 [135], other findings have associated NURR1 expression levels with increased proinflammatory cytokines, in particular in pathologies such as PD and type 2 diabetes, suggesting a potential of NURR1 in the etiology of these conditions [11,93]. Here, NR4A2 is linked to Parkinson disease.